Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disturbance; Vision, Loss”

114 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 114 results

Not applicableNot Yet RecruitingNCT03166072
What this trial is testing

Health Education vs Meditation in Irreversible Age-Related Vision Loss Patients and Their Caregivers

Who this might be right for
Low Vision, One Eye, Unspecified EyeLow Vision Blindness
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 150
Not applicableLooking for participantsNCT06047717
What this trial is testing

Vision Loss Impact on Navigation in Virtual Reality

Who this might be right for
Stroke, IschemicQuadrantanopiaHemianopsia, Homonymous+8 more
University of Rochester 40
Not applicableStudy completedNCT05098236
What this trial is testing

Effect of Visual Retraining on Visual Loss Following Visual Cortical Damage

Who this might be right for
Vision Loss PartialHemianopiaHemianopia Homonymous+2 more
University of Rochester 280
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Not applicableNot Yet RecruitingNCT05780931
What this trial is testing

Rehabilitating Vision Loss in Veterans With Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration (AMD)
VA Office of Research and Development 20
Not applicableLooking for participantsNCT05454124
What this trial is testing

Factors in Learning And Plasticity: Macular Degeneration

Who this might be right for
Central Visual ImpairmentMacular Degeneration
University of Alabama at Birmingham 60
Large-scale testing (Phase 3)Ended earlyNCT05176717
What this trial is testing

Study to Evaluate the Efficacy Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene With Early to Moderate Vision Loss (Celeste)

Who this might be right for
Retinitis PigmentosaUsher Syndrome Type 2Deaf Blind+5 more
Laboratoires Thea 5
Large-scale testing (Phase 3)Study completedNCT04047472
What this trial is testing

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 397
Not applicableStudy completedNCT01262209
What this trial is testing

Clinical Effectiveness of Low Vision Rehabilitation in Glaucoma Patients

Who this might be right for
Glaucoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 16
Not applicableUnknownNCT04878861
What this trial is testing

Rehabilitating Visual Deficits Caused by Stroke

Who this might be right for
HemianopiaHemianopsiaQuadrantanopia+1 more
University of Oxford 20
Not applicableStudy completedNCT01366677
What this trial is testing

Yoga for Persons With Severe Visual Impairment

Who this might be right for
Sleep DisturbanceStressAnxiety+2 more
Johns Hopkins University 21
Not applicableStudy completedNCT03350919
What this trial is testing

Visual Restoration for Hemianopia

Who this might be right for
Stroke Induced Vision LossHemianopiaQuadrantanopia
University of Rochester 48
Large-scale testing (Phase 3)UnknownNCT00559715
What this trial is testing

Prevention of Vision Loss in Patients With Age-Related Macular Degeneration (AMD) by Intravitreal Injection of Bevacizumab and Ranibizumab

Who this might be right for
Age-Related Neovascular Macular Degeneration
Klinikum Bremen-Mitte, gGmbH 366
Large-scale testing (Phase 3)Study completedNCT00604383
What this trial is testing

Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study

Who this might be right for
Diabetic Retinopathy
Chromaderm, Inc. 685
Post-approval studies (Phase 4)Ended earlyNCT00867815
What this trial is testing

PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

Who this might be right for
Anterior Ischemic Optic Neuropathy
Bayer 10
Not applicableStudy completedNCT06176625
What this trial is testing

Sight and Hearing Investigation Into Effects on Delirium

Who this might be right for
Hearing LossHearing Loss, Age-RelatedHearing Disability+14 more
Johns Hopkins University 1,543
Large-scale testing (Phase 3)Study completedNCT04005352
What this trial is testing

Study to Assess the Efficacy and Safety of Brolucizumab 6mg Compared to Aflibercept 2 mg in a Treat-to-control Regimen (TALON)

Who this might be right for
Age-related Macular Degeneration
Novartis Pharmaceuticals 734
Testing effectiveness (Phase 2)Study completedNCT01243086
What this trial is testing

OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab

Who this might be right for
Wet Macular Degeneration
McMaster University 10
Not applicableWithdrawnNCT05948501
What this trial is testing

The Effects of Concussion on Gait and Posture in Individuals With Peripheral Vision Loss

Who this might be right for
ConcussionEye
Gaylord Hospital, Inc
Not applicableStudy completedNCT04043949
What this trial is testing

The Influences of Dry Eye Disease on Optical Quality

Who this might be right for
Dry EyeVision; Disturbance, Hysterical
Peking University Third Hospital 90
Load More Results